And Japan? [BE/BA News]

posted by ElMaestro  – Belgium?, 2019-12-04 14:43  – Posting: # 20923
Views: 110

Wow,

» A: The guideline focuses on BCS-based biowaiver principles to be applied for bioequivalence purposes provided they are supported by a sound scientific rationale. The provision in the guideline that accommodates exceptions to existing regulations that do not permit BCS-based biowaivers for generic product applications, at this time, does not disqualify implementation of these harmonized technical requirements to demonstrate BCS based biowaivers for other product applications unless explicitly stated.

I tried to read that answer 10 times now and I am none the wiser. Do they mean "The guideline will deal with BCS-based biowaivers, but it is acknowledged that some countries might not accept those." ??
:-)

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Admin contact
20,101 posts in 4,243 threads, 1,382 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 21:47 CET

Trust, but verify.    Anonymous (Russian proverb)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5